TerminatedNot Applicable

Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

Stopped: Poor enrollment of study population

United States12 participantsStarted 2014-04

Plain-language summary

Pentoxyfylline therapy in addition to the standard of care of albumin, midodrine and octreotide therapy is superior to the standard of care alone in the treatment of Type I hepatorenal syndrome in the first 14 days of hospitalization.

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Hospitalized patients with acute or chronic liver disease * Type I HRS * Aged greater than or equal to 18 * Non-pregnant Exclusion Criteria: * Allergy or hypersensitivity to PTX or intolerance to methylxanthines (e.g. caffeine, theophylline) * Concurrent use of nephrotoxic drugs * Age less than 18 * Pregnancy * Uncontrolled bacterial infection * Renal parenchymal disease (e.g. acute tubular necrosis, glomerular disease, interstitial nephritis and urinary obstruction) * Shock * TNF alpha antagonist use * Subject is institutionalized or a prisoner * Recent cerebral or retinal hemorrhage (contraindication to PTX) * Severe or poorly controlled cardiovascular disease as determined by the principal investigator to hinder the ability to adhere to study protocols

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of Participants With Treatment Success

Timeframe: 14 days

Trial details

NCT IDNCT02123576

SponsorPatrick Northup, MD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-12-31

Results submitted2018-10-10

View on ClinicalTrials.gov More Hepatorenal Syndrome trials

Who can participate

Age range

18 Years – 75 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.